Show items per page
Elements: 8
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy Du Pasquier, Renaud Alfred Robert; Jilek, Samantha; Kalubi, Malela; Yerly Ferrillo, Sabine; ... Vernazza, Pietro L 2013
add to browser selection
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study Young, J; Scherrer, Anne Paule Marie; Günthard, H F; Opravil, M; ... Bucher, H C 2011
add to browser selection
The Monark trial: where now for boosted protease inhibitor monotherapy? Hill, Andrew; Hirschel, Bernard; Katlama, Christine 2008
add to browser selection
Initial treatment for HIV infection--an embarrassment of riches Hirschel, Bernard; Calmy, Alexandra 2008
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey Yerly Ferrillo, Sabine; von Wyl, Viktor; Ledergerber, Bruno; Boni, Jurg; ... Perrin, Luc 2007
add to browser selection
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study Zinkernagel, C.; Ledergerber, Bruno; Battegay, M.; Cone, R. W.; ... Opravil, M. 1999
add to browser selection
Progress and problems in the fight against AIDS Hirschel, Bernard; Francioli, P. 1998